NCT-SEED-002Phase 3Active not recruiting
SGLT2 Inhibitor Heart Failure Outcomes Study
Phase
Phase 3
Enrollment
3,100
Location
United Kingdom
Trial information
- Registry ID
- NCT-SEED-002
- Status
- Active not recruiting
- Phase
- Phase 3
- Sponsor
- International Heart Research Consortium
- Country
- United Kingdom
- Target enrollment
- 3,100